This video features an informative discussion between Jessica Mullenix and Dr. Ulrika Birgersdotter-Green about implantable cardioverter-defibrillators (ICDs). They explore how these devices function as a protective backup for abnormal heart rhythms and explain the differences between traditional and newer technologies.
Key Takeaways
- What is an ICD?: It acts like an "internal AED," monitoring the heart rhythm and delivering a shock if a life-threatening abnormal rhythm is detected (-).
- Traditional Transvenous ICD: The standard device for the last 25 years, involving leads placed directly into the bloodstream through a vessel under the collarbone. While effective, it carries long-term risks like infection or difficult lead removal (-).
- Extravascular ICD (EV-ICD): A newer alternative where the lead is placed under the breastbone rather than in the bloodstream. This design aims to avoid vascular complications and provides a more discreet placement on the side of the chest (-).
- Subcutaneous ICD (S-ICD): Another option where the lead runs along the breastbone. It is a straightforward procedure but requires a larger device and lacks the pacing capabilities of the EV-ICD (-).
- Key Feature: Anti-Tachycardia Pacing (ATP): The EV-ICD can use "pacing" to treat fast heart rhythms, potentially stopping them without requiring a shock, which is a significant advantage for patient comfort (-).
- Shared Decision-Making: Dr. Birgersdotter-Green emphasizes that patients should have an open discussion with their care team about these options to choose the best device for their individual lifestyle and medical needs (-, -).